相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Review Article Genotype and phenotype of COVID-19: Their roles in pathogenesis
Leila Mousavizadeh et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)
The coding capacity of SARS-CoV-2
Yaara Finkel et al.
NATURE (2021)
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Structure analysis of the receptor binding of 2019-nCoV
Yun Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Evidence for Gastrointestinal Infection of SARS-CoV-2
Fei Xiao et al.
GASTROENTEROLOGY (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Hussin A. Rothan et al.
JOURNAL OF AUTOIMMUNITY (2020)
Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV
Jia Liu et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Yu Chen et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths
Chih-Cheng Lai et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
Jasper Fuk-Woo Chan et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Guangdi Li et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Lirong Zou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
Yajing Fu et al.
VIROLOGICA SINICA (2020)
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furinlike cleavage site absent in CoV of the same clade
B. Coutard et al.
ANTIVIRAL RESEARCH (2020)
COVID-19 in the heart and the lungs: could we Notch the inflammatory storm?
Paola Rizzo et al.
BASIC RESEARCH IN CARDIOLOGY (2020)
Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase
Quan Wang et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
Jasper Fuk-Woo Chan et al.
EMERGING MICROBES & INFECTIONS (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies
Ming Zhao
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
COVID-19 may transmit through aerosol
Juan Wang et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2020)
Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
Tobias Herold et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Current epidemiological and clinical features of COVID-19; a global perspective from China
Huilan Tu et al.
JOURNAL OF INFECTION (2020)
Elevated interleukin-6 and severe COVID-19: A meta-analysis
Muhammad Aziz et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Virology, Epidemiology, Pathogenesis, and Control of COVID-19
Yuefei Jin et al.
VIRUSES-BASEL (2020)
Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review
Anwar M. Hashem et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung et al.
LANCET (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
Zou Xin et al.
FRONTIERS OF MEDICINE (2020)
Chloroquine paradox may cause more damage than help fight COVID-19
Anuj Sharma
MICROBES AND INFECTION (2020)
SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes
Janko Nikolich-Zugich et al.
GEROSCIENCE (2020)
Covid-19-The Search for Effective Therapy
Lindsey R. Baden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Molecular immune pathogenesis and diagnosis of COVID-19
Xiaowei Li et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 A Randomized Trial
Caleb P. Skipper et al.
ANNALS OF INTERNAL MEDICINE (2020)
Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab
Austin R. Morrison et al.
JOURNAL OF AUTOIMMUNITY (2020)
The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19
Qing Ye et al.
JOURNAL OF INFECTION (2020)
Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19
Minchen Chien et al.
JOURNAL OF PROTEOME RESEARCH (2020)
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
J. M. Molina et al.
MEDECINE ET MALADIES INFECTIEUSES (2020)
Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting
Fran Robson et al.
MOLECULAR CELL (2020)
Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic
Rodrigo Jacome et al.
SCIENTIFIC REPORTS (2020)
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial
Anahita Sadeghi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19
Gholamali Eslami et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity
Suzanne J. F. Kaptein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Neuropilin-1 is a host factor for SARS-CoV-2 infection
James L. Daly et al.
SCIENCE (2020)
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis
Ashleigh Shannon et al.
NATURE COMMUNICATIONS (2020)
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike
Michael Schoof et al.
SCIENCE (2020)
Genomics functional analysis and drug screening of SARS-CoV-2
Long Chen et al.
GENES & DISEASES (2020)
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
Bo Ram Beck et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis
Vineet D. Menachery et al.
MBIO (2017)
Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014
Dianna L. Ng et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Coronaviruses - drug discovery and therapeutic options
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
SARS and MERS: recent insights into emerging coronaviruses
Emmie de Wit et al.
NATURE REVIEWS MICROBIOLOGY (2016)
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
Vineet D. Menachery et al.
NATURE MEDICINE (2015)
MERS coronavirus: diagnostics, epidemiology and transmission
Ian M. Mackay et al.
VIROLOGY JOURNAL (2015)
Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis
Jean Kaoru Millet et al.
VIRUS RESEARCH (2015)
Accessory proteins of SARS-CoV and other coronaviruses
Ding Xiang Liu et al.
ANTIVIRAL RESEARCH (2014)
Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein
Jean Kaoru Millet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi Arabia
A. N. Alagaili et al.
mBio (2014)
Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus
Anna Lundin et al.
PLOS PATHOGENS (2014)
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
Xing-Yi Ge et al.
NATURE (2013)
Infectious Bronchitis Virus Generates Spherules from Zippered Endoplasmic Reticulum Membranes
Helena J. Maier et al.
MBIO (2013)
Severe Acute Respiratory Syndrome Coronavirus Nonstructural Proteins 3, 4, and 6 Induce Double-Membrane Vesicles
Megan M. Angelini et al.
MBIO (2013)
The Coronavirus E Protein: Assembly and Beyond
Travis R. Ruch et al.
VIRUSES-BASEL (2012)
Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans
Sander van Boheemen et al.
MBIO (2012)
Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: Involvement of p38 MAPK and ERK
Masakazu Kono et al.
ANTIVIRAL RESEARCH (2008)
Pacing a small cage: mutation and RNA viruses
Robert Belshaw et al.
TRENDS IN ECOLOGY & EVOLUTION (2008)
Coronavirus nucleocapsid protein is an RNA chaperone
Sonia Zuniga et al.
VIROLOGY (2007)
Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex
Eric J. Snijder et al.
JOURNAL OF VIROLOGY (2006)
Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry
G Simmons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The clinical pathology of severe acute respiratory syndrome (SARS): a report from China
YQ Ding et al.
JOURNAL OF PATHOLOGY (2003)
Virus-encoded proteinases and proteolytic processing in the Nidovirales
J Ziebuhr et al.
JOURNAL OF GENERAL VIROLOGY (2000)
The viral nucleocapsid protein of transmissible gastroenteritis coronavirus (TGEV) is cleaved by caspase-6 and-7 during TGEV-induced apoptosis
JF Eléouët et al.
JOURNAL OF VIROLOGY (2000)
分享论文
